Printer Friendly

Browse Pharmaceutical industry topic

Intellectual property subtopic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
Can-Fite Receives Notice of Allowance From U.S. Patent and Trademark Office for Erectile Dysfunction Drug. Nov 9, 2016 1070
Canada : Canada's drug price watchdog reaches agreement with drug-maker on reporting requirements for leukemia drug. Nov 4, 2016 294
Switzerland : Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters. Oct 27, 2016 889
Big Pharma Focus on Building Patent Portfolio to Gain Competitive Edge in Biologics Sector. Oct 25, 2016 894
Big Pharma Focus on Building Patent Portfolio to Gain Competitive Edge in Biologics Sector. Oct 25, 2016 930
Global Generic Drugs and Strategies for Commercial Success Report 2016-2021: Promise of Significant Revenues From Blockbuster Drugs Nearing Patent Expiry - Research and Markets. Oct 24, 2016 577
Global Generic Drugs and Strategies for Commercial Success Report 2016-2021: Promise of Significant Revenues From Blockbuster Drugs Nearing Patent Expiry - Research and Markets. Oct 24, 2016 617
United Kingdom : Lyrica patent infringement case. Oct 20, 2016 206
Patent Trial and Appeal Board Upholds the Validity of LIALDA Patent. Oct 5, 2016 1850
Patent Trial and Appeal Board Upholds the Validity of LIALDA Patent. Oct 5, 2016 1855
Impending Expiry of Patents Make BASF, Bayer, and Syngenta Vulnerable in the Global Crop Protection Chemicals Market. Sep 27, 2016 480
XTL Biopharmaceuticals Reports Second Quarter 2016 Financial Results & Provides Clinical and Operational Update. Financial report Sep 27, 2016 2515
Can-Fite Receives Notice of Allowance for Psoriasis Patent in Europe Ahead of Phase III Trial. Sep 13, 2016 1028
XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug hCDR1. Sep 7, 2016 1032
United Kingdom : Firstsource launches UKs first contact centre boot camp. Sep 2, 2016 355
Mylan Invalidates Third Teva Copaxone 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding. Sep 1, 2016 502
USPTO Dismisses Petition for Inter Partes Review of Fanapt Patent. Aug 30, 2016 329
United States : Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation. Aug 29, 2016 167
Israel : Teva Confirms PTABs Decisions on Two Patents in IPR Challenge to COPAXONE 40 mg. Aug 29, 2016 235
United Kingdom : Mylan Invalidates Two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding. Aug 26, 2016 287
Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation. Aug 25, 2016 328
Johnson & Johnson Announces Ruling Related to REMICADE in the District of Massachusetts Federal Court Hearing. Aug 17, 2016 532
XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1. Aug 11, 2016 1167
Kitov Announces Issuance of U.S. Patent Securing Long-Term Exclusivity for KIT-302 Ahead of New Drug Application to the FDA. Aug 10, 2016 892
Global Pain Management Therapeutics Market - Patent Expiries of Blockbuster Drugs to Intensify Challenges for Branded Drugs, States TMR; Industry Analysis, Size, Share, Growth, Trends, Forecast up to 2023. Aug 2, 2016 1315
Global Pain Management Therapeutics Market - Patent Expiries of Blockbuster Drugs to Intensify Challenges for Branded Drugs, States TMR; Industry Analysis, Size, Share, Growth, Trends, Forecast up to 2023. Aug 2, 2016 1321
Bayer's Stivarga Patent Challenged in Inter Partes Review. Jul 27, 2016 482
Depomed Announces Patent Trial and Appeal Board Denial of Inter Partes Review of NUCYNTA Patent. Jul 18, 2016 463
Testosterone Replacement Therapy (TRT) Market to Face Lean Patch until 2024 as it Inches Close to Patent Cliff, Says TMR. Jul 12, 2016 1259
Testosterone Replacement Therapy (TRT) Market to Face Lean Patch until 2024 as it Inches Close to Patent Cliff, Says TMR. Jul 12, 2016 1253
The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments. Jul 7, 2016 824
The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments. Jul 7, 2016 830
March 31--multinational pharma giant GSK announces an intellectual property policy intended to improve access to innovative drugs and treatments for developing nations. Brief article Jul 1, 2016 179
Regen BioPharma, Inc. Enters Into Open Innovation Drug Discovery Program Agreement with Eli Lilly and Company. Jun 30, 2016 610
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant. Jun 14, 2016 1145
German Supreme Court Grants Lilly Appeal in Alimta Vitamin Regimen Patent Lawsuit. Jun 14, 2016 703
Perrigo Confirms First To File Patent Challenge For Generic Version Of Picato Gel (0.015% And 0.05%). Jun 13, 2016 802
ICENI PHARMACEUTICALS LAUNCHES AS NEW COMPANY. Jun 1, 2016 628
XTL Biopharmaceuticals Reports First Quarter 2016 Financial Results & Provides Clinical and Operational Update. Financial report Jun 1, 2016 3319
Purdue Pharma Announces Patent Agreement with Egalet and Acura. May 23, 2016 487
Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against UCB's VIMPAT. May 23, 2016 434
DURECT Announces New REMOXY Data being Presented at American Pain Society Meeting. May 11, 2016 914
Symberix Adds Pharmaceutical Industry Executive to Board of Directors, Expands Key Patent Asset and Joins Blackstone Entrepreneurs Network. May 10, 2016 884
Endo Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property. May 2, 2016 584
Endo Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property. May 2, 2016 624
United Kingdom : ViiV Healthcare extends Medicines Patent Pool licence agreement for dolutegravir to cover all lower middle-income countries. Apr 26, 2016 518
J&J patents sunscreen with UV radiation-absorbing polymer. Apr 1, 2016 104
Shire Wins Patent Trial Against Watson Concerning LIALDA. Mar 29, 2016 1977
Shire Wins Patent Trial Against Watson Concerning LIALDA. Mar 29, 2016 1982
SHIRE PLC - Shire Wins Patent Trial Concerning LIALDA. Mar 29, 2016 2205
Japan : Favorable Grand Panel Judgment on Patent-Infringement Lawsuit Regarding OXAROL Ointment at the Intellectual Property High Court. Mar 26, 2016 351
A fair return approach to pharmaceutical compulsory licensing. Nuno, Maura Mar 22, 2016 7932
Ionis Pharmaceuticals and Merck Receive Positive Verdict on Gilead HCV Drug Patent Case. Mar 22, 2016 846
Amgen Wins Patent Case On Repatha (Evolocumab). Mar 16, 2016 1172
Katama Pharmaceuticals Receives a Notice of Allowance of a Composition of Matter Patent For Tolperisone. Mar 9, 2016 912
XTL Biopharmaceuticals Expands Global IP Portfolio With Issued Patent in Hungary for Lupus Drug hCDR1. Mar 2, 2016 1024
Novogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant. Feb 19, 2016 1233
UK Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit. Feb 12, 2016 870
XTL Biopharmaceuticals' Lupus Drug hCDR1 Granted Patent for Pharmaceutical Composition & Manufacturing Processes. Feb 10, 2016 1129
The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir. Jan 20, 2016 904
The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir. Jan 20, 2016 910
U.S. Patent & Trademark Office Issues Notice of Allowance for Can-Fite's Sexual Dysfunction Drug CF602. Jan 19, 2016 933
United States : Patenting Activity in Pharma Sector Strongest in China among BRIC Nations, Finds Frost & Sullivan. Dec 24, 2015 255
Patenting Activity in Pharma Sector Strongest in China among BRIC Nations, Finds Frost & Sullivan. Dec 23, 2015 1179
Patenting Activity in Pharma Sector Strongest in China among BRIC Nations, Finds Frost & Sullivan. Dec 23, 2015 1143
Can-Fite's CF101 Granted Patent in Japan for Intraocular Pressure a Key Cause of Glaucoma. Dec 17, 2015 1102
GenVec Receives Notice of Allowance for Patent Application Providing Broad Protection of Its Gorilla Adenovectors. Dec 2, 2015 814
Facebook debate: Pharmaceutical patents. Nov 28, 2015 490
The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine daclatasvir. Nov 23, 2015 836
The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine daclatasvir. Nov 23, 2015 842
Mylan Confirms First-to-File Patent Challenge Relating to DELZICOL. Nov 19, 2015 697
United States : Successful ruling in patent infringement litigation for Antiemetic agent Aloxi in the United states. Nov 19, 2015 423
Successful Ruling in Patent Infringement Litigation for Antiemetic Agent Aloxi in the United States. Nov 17, 2015 959
Novogen Patent Covering Cantrixil and Trilexium Accepted in Australia. Nov 12, 2015 1332
purchase of Non Patent Drugs-Liq.Dettol Handwash,Liq.Lifebuoy Handwash,Uq. Dettol,Liq. Savbn,Liq. Parrafine,Liq.Turpentine ,Liq.Betadine,Liq.Betadine scrub,Liq.Tr. Iodine,liq.Benzoin,Liq.Hydrogen peri. Nov 3, 2015 163
United States : ARENA PHARMA confirms more patent released securing BELVIQ. Oct 29, 2015 216
The Medicines Patent Pool Announces Expansion of its Governance Board. Oct 27, 2015 1134
The Medicines Patent Pool Announces Expansion of its Governance Board. Oct 27, 2015 1140
Arena Pharmaceuticals Issued Additional Patent Covering BELVIQ (lorcaserin HCl) by United States Patent and Trademark Office. Oct 27, 2015 2356
Lilly Reports Third-Quarter 2015 Results, Revises 2015 Financial Guidance. Financial report Oct 22, 2015 25021
Strategic Overview of Patenting Activity in Pharma Sector of BRIC Countries - Reportlinker Review. Oct 15, 2015 734
Cavendish Leads on the Sale of Off-Patent Branded Pharmaceuticals Provider DB Ashbourne to Top French Pharmaceutial Company Ethypharm. Oct 2, 2015 469
GenVec Expands I.P. Portfolio With Issuance Of U.S. And European Patents For Monkey Adenoviral Vectors. Sep 28, 2015 681
Sanofi Reaches Patent Settlement on Lantus SoloSTAR. Sep 28, 2015 751
Appeals Court Affirms Shire's Vyvanse (lisdexamfetamine dimesylate) Patents Are Valid Until 2023. Sep 24, 2015 1776
Appeals Court Affirms Shire's Vyvanse (lisdexamfetamine dimesylate) Patents Are Valid Until 2023. Sep 24, 2015 1779
SHIRE PLC - Appeals Court Affirms Shire's Patents. Sep 24, 2015 1941
Depomed Announces Two Favorable Decisions in Inter Partes Review Proceedings Versus Endo Pharmaceuticals. Sep 23, 2015 976
Purdue Pharma L.P. and AnaBios Corporation Initiate Program to Accelerate Development of Chronic Pain Treatment. Sep 22, 2015 744
Allergan Confirms Generic Rytary Patent Challenge. Sep 21, 2015 809
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer. Sep 15, 2015 716
Vanda Announces Favorable Markman Ruling in Fanapt Patent Infringement Litigation. Sep 10, 2015 837
Omeros Files Infringement Suits Against Par. Sep 3, 2015 1037
U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent. Aug 25, 2015 612
Omeros Announces Plan to File Infringement Suit Against ANDA Filer. Aug 17, 2015 1254
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Appeal Maintaining Exclusivity Through 2026. Aug 11, 2015 1029
Allergan Confirms Generic Noxafil Patent Challenge. Aug 11, 2015 839
UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit. Jun 25, 2015 870
Can-Fite Granted Notice of Allowance for Patent Covering Manufacturing Process of CF101 in the U.S. Jun 10, 2015 873
Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel'. Jun 8, 2015 999
Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel'. Jun 8, 2015 1004
ATM Technology Extended with New Patent Lodgement. May 28, 2015 1455
Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle. May 19, 2015 904
LCS Group Announces Exclusive License from Lucerne Biosciences to Commercialize '813 Patent and '249 Application through Shire's Marketing of Lisdexamfetamine Dimesylate for Binge Eating Disorder. May 13, 2015 855
Mylan Confirms First-to-File Patent Challenge Relating to Minivelle. May 5, 2015 722
PFIZER AND PROVECTUS RECEIVE PATENT ALLOWANCE. May 1, 2015 502
Johnson & Johnson Announces Further Patent and Trademark Office Action Related to REMICADE. Apr 29, 2015 411
Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel'. Apr 27, 2015 1119
Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel'. Apr 26, 2015 1122
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica[R]. Apr 24, 2015 1182
Breathe eCig Corp. Appoints Veteran Pharmaceutical Industry Executive Frank P. Orlowski as Advisory Board Member. Apr 21, 2015 1112
Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case. Apr 21, 2015 937
Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan. Apr 21, 2015 1180
Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan. Apr 20, 2015 1203
Vanda Announces Trial Date for Fanapt Patent Cases. Apr 13, 2015 582
Arena Pharmaceuticals Receives Additional Patent for BELVIQ (lorcaserin HCl) from United States Patent and Trademark Office. Apr 7, 2015 2323
Actavis Confirms Generic Letairis Patent Challenge. Apr 3, 2015 934
German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit. Mar 6, 2015 693
DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083. Mar 2, 2015 1047
Switzerland : ABB again heads list for most patent applications filed by a Swiss-based company. Feb 28, 2015 458
Actavis Confirms Generic Uceris Patent Challenge. Feb 24, 2015 867
Can-Fite Receives Notice of Allowance in U.S. for Psoriasis Patent. Feb 17, 2015 1188
Kinex Pharmaceuticals Licenses Patents from Hong Kong Polytechnic University. Feb 13, 2015 774
Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE. Feb 12, 2015 354
Novogen Lodges Key Super-benzopyran Patent. Feb 11, 2015 1078
Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR. Feb 9, 2015 621
ContraVir Pharmaceuticals' HBV Compound CMX157 Receives Extended Patent Life. Feb 4, 2015 890
No more do-overs; Teva wins Supreme Court ruling to delay rivals. Stohr, Greg Jan 21, 2015 559
New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain. Jan 20, 2015 1951
U.S. Supreme Court Partially Modifies Standard of Review of Patent Claim Construction and Remands Review of Teva's '808 Patent on Copaxone to Federal Circuit Court of Appeals. Jan 20, 2015 568
DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083. Jan 13, 2015 837
Japan : Chugai Wins the First Instance of the Patent Infringement Lawsuit for Oxarol Ointment. Dec 26, 2014 194
Celator Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology. Dec 18, 2014 990
Wilshire Confirms First-to-File Patent Challenge Relating to LASTACAFT. Dec 11, 2014 793
KemPharm, Inc. Receives Notice of Allowance for NME Prodrug of Methylphenidate, KP415. Dec 5, 2014 620
Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC. Nov 25, 2014 619
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds. Nov 25, 2014 1431
Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed (Testosterone Undecanoate) Injection. Nov 24, 2014 849
Orexigen Announces Allowance of New U.S. Patent for Contrave (naltrexone HCl / bupropion HCl extended release). Nov 21, 2014 2619
Small Cap IR Initiates Coverage of Can-Fite Biopharma: Newly Discovered Late Clinical Stage BioPharma Vendor with Potentially Revolutionary Breakthroughs. Nov 19, 2014 823
Patents. Nov 1, 2014 131
Metrics Contract Services Scientist Awarded Patent for Zero-Order Release Tablet Technology. Oct 30, 2014 681
Pharmalink Extends Patent Protection for Nefecon Treatment for Renal Disease. Oct 27, 2014 671
Pharmalink Extends Patent Protection for Nefecon Treatment for Renal Disease. Oct 27, 2014 676
Lilly Reports Third-Quarter 2014 Results. Financial report Oct 23, 2014 17697
CANDA NK-2 Files Motion to Dismiss Patent Infringement Suit. Oct 22, 2014 404
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement. Oct 17, 2014 427
AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM) and its Proprietary Platform Technologies. Oct 16, 2014 991
Actavis Confirms Generic Quillivant XR Patent Challenge. Oct 16, 2014 896
Mission Pharmacal Settles Patent Infringement Suit With Virtus Pharmaceuticals. Oct 14, 2014 791
U.S. Patent and Trademark Office Issues Can-Fite Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery. Sep 30, 2014 1047
Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration. Sep 25, 2014 1153
Actavis Confirms Generic Butrans Patent Challenge. Sep 25, 2014 774
How to slow a diabetes epidemic. Rubin, Paul H. Sep 22, 2014 940
Indian pharmaceutical patent law and the effects of Novartis AG v. Union of India. Bennett, William J. Sep 22, 2014 12119
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent. Sep 19, 2014 1944
Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer. Sep 18, 2014 836
FTC Sues Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of the Blockbuster Drug AndroGel. Sep 8, 2014 1186
Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery. Sep 5, 2014 1046
DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083. Sep 3, 2014 644
Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent. Sep 2, 2014 1133
District Court Decision Received In Remodulin Patent Case. Aug 29, 2014 510
Actavis Confirms Generic Neupro Patent Challenge. Aug 22, 2014 953
Nanowire LEDs Patent Investigation. Aug 19, 2014 863
Access Pharmaceuticals Awarded Japan Patent For MuGard And ProctiGard. Aug 14, 2014 996
Global Human Growth Hormone Drugs Industry. Aug 12, 2014 2683
Columbia Laboratories Announces Sale Of IP And Technology For Legatrin P.M. To Lil' Drug Store Products. Aug 6, 2014 279
Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort Topical Spray 0.25%. Jul 30, 2014 720
Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent. Jul 17, 2014 744
Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion. Jul 17, 2014 811
Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office. Jul 15, 2014 1199
Brandsymbol Partners with Med-ERRS to Cultivate Safe Pharmaceutical Trademarks. Jul 11, 2014 580
Actavis Confirms Generic Diclegis Patent Challenge. Jul 11, 2014 912
Pharmalink's Core Patents for Nefecon Treatment for Renal Disease Granted in United States, Europe, China and Hong Kong. Jul 10, 2014 800
Pharmalink's Core Patents for Nefecon Treatment for Renal Disease Granted in United States, Europe, China and Hong Kong. Jul 10, 2014 795
Access Pharmaceuticals Awarded Hong Kong Patent For MuGard. Jul 8, 2014 856
Actavis Confirms Generic Ampyra Patent Challenge. Jul 8, 2014 908
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma. Jul 4, 2014 1510
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW. Jun 30, 2014 1643
Actavis Confirms Generic Zubsolv Patent Challenge. Jun 30, 2014 934
Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta. Jun 30, 2014 1717
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell. Jun 26, 2014 1559
Vyvanse Patents Found to Be Infringed and Valid by U.S. District Court. Jun 25, 2014 2192
Vyvanse Patents Found to Be Infringed and Valid by U.S. District Court. Jun 25, 2014 2187
Germany : Bayer CropScience settles Serenade-related litigation with Bion Tech Inc. Jun 24, 2014 319
One view of compulsory licensing: comparative perspectives from India and Canada. Ramanujam, Padmanabha; Goyal, Yugank Jun 22, 2014 16690
Agile Therapeutics Announces Issuance of New Patent for Its Skinfusion Transdermal Delivery Device. Jun 20, 2014 777
Actavis Confirms District Court Ruling In Generic Exelon Patch Patent Suit. Jun 19, 2014 813
Ireland : ACTAVIS finalises agreement to settle patent issue. Jun 11, 2014 133
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries. Jun 10, 2014 1903
United States : AMAG Pharmaceuticals issues US patent term extension certificate. Jun 10, 2014 193
Neurodegenerative Diseases Market to 2018 - New Product Entries in both Niche and Broader Parkinson's Disease Treatment will Boost Market Despite Patent Cliff. Jun 9, 2014 4813
United States Patent Issued To Adamas Pharmaceuticals. Jun 9, 2014 611
Actavis Finalizes Agreement Related to Asacol HD Patent Challenge Litigation. Jun 9, 2014 738
ChromaDex Licenses Exclusive Patent Rights from Dartmouth College for Pharmaceutical Use of Nicotinamide Riboside (NR). Jun 3, 2014 1692
Merck patents pigment preparations. Jun 1, 2014 155
Actavis Announces Nuvigil Patent Challenge Settlement. May 30, 2014 925
Actavis Confirms Generic Onglyza Patent Challenge. May 27, 2014 787
United States : NOVARTIS settles litigation agreement with ACURA. May 26, 2014 283
RXi Pharmaceuticals Granted US Notice of Allowance Covering Self-Delivering (sd-rxRNA) Technology Platform. May 22, 2014 936
English Court Rules Against Lilly in Alimta Vitamin Dosage Regimen Patent Lawsuit. May 15, 2014 753
Actavis Announces Acanya Gel Patent Challenge Settlement. May 12, 2014 918
Valeant Pharmaceuticals Enters Into Patent Settlement Agreements With Actavis. May 12, 2014 676
United States : ACUR inks Settlement deal with RANBAXY. May 9, 2014 166
Global Biosimilars Market 2014-2018: A Number of Biopharmaceutical Patents are Due to Expire in the Near Future or Have Already Expired. Industry overview May 9, 2014 702
Global Biosimilars Market 2014-2018: A Number of Biopharmaceutical Patents are Due to Expire in the Near Future or Have Already Expired. Industry overview May 9, 2014 696
Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery. May 7, 2014 1017
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co. Apr 30, 2014 1572
Multinational Companies Are Developing New Pharmaceutical Pricing and Market Access Strategies For India's Pharmaceutical Market. Apr 30, 2014 746
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026. Apr 30, 2014 1025
Mylan Challenges FDA Ruling on Exclusivity Relating to Celecoxib. Apr 25, 2014 562
Lilly Reports First-Quarter 2014 Results. Financial report Apr 24, 2014 9800
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie. Apr 24, 2014 1616
Actavis Announces Celebrex Patent Challenge Settlement. Apr 24, 2014 780
Actavis Announces Agreement Related to Generess FE Patent Challenge Litigation. Apr 15, 2014 815
Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regarding Generic FROVA. Apr 11, 2014 588
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb Antibody Engineering Intellectual Property. Apr 10, 2014 754
Regulus Presents Positive Preclinical Data on miR-21 and miR-221 Oncology Programs In Oral and Poster Presentations at AACR 2014 Annual Meeting. Apr 7, 2014 1306
Industry-Leading Companies Announce New Partnership for American Innovation. Apr 3, 2014 659
United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone for the Second Time. Apr 3, 2014 435
Germany : CNT intellectual property sold by Bayer to FutureCarbon. Apr 2, 2014 235
U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022. Mar 31, 2014 521
Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction. Mar 31, 2014 660
Actavis Confirms Favorable Ruling in Generic Lialda Patent Suit. Mar 28, 2014 718
Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important Addition to its Intellectual Property Portfolio for Brisdelle (Paroxetine) Capsules, 7.5 mg. Mar 25, 2014 1951
District Court Upholds Mylan's U.S. Patents on Perforomist Inhalation Solution. Mar 24, 2014 584
Supply Agreements, Patents, Appointments, and FDA Clearances - Analyst Notes on OPKO, Synageva, Hill-Rom, Anacor, and Cardiovascular Systems. Mar 20, 2014 1525
Actavis Announces Daytrana Patent Challenge Settlement. Mar 19, 2014 890
Healthcare Companies Receive Approvals, Recognitions, Agreements, and Announce Senior Level Appointments- Analyst Notes on Pfizer, Boston Scientific, WellPoint, Aetna, and Humana. Mar 18, 2014 1653
Mylan Comments on Favorable Ruling in Generic Celebrex Patent Suit. Mar 13, 2014 535
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta(TM), for Multiple Sclerosis. Mar 10, 2014 912
RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders. Mar 5, 2014 749
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza. Mar 5, 2014 827
Actavis Confirms Generic Multaq Patent Challenge. Feb 28, 2014 909
Actavis Confirms Generic Colcrys Patent Challenge. Feb 28, 2014 870
Can-Fite Granted Patent on the Manufacturing of CF101 in Japan. Feb 25, 2014 950
CII feels International IP Index does not give true picture of India's IP ecosystem. Feb 11, 2014 554
Big pharma seeks US action against India over patents. Feb 6, 2014 659
Actavis Confirms Generic Treanda Patent Challenge. Feb 4, 2014 865
Ferring Pharmaceuticals Inc. Receives Positive Verdict in Patent Infringement Lawsuit for LYSTEDA (tranexamic acid). Feb 3, 2014 822
Japan companies patent coating composition. Feb 1, 2014 144
Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGAN 0.01%. Jan 15, 2014 467
RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders. Jan 14, 2014 782
Mylan Launches Generic Myfortic Delayed-Release Tablets. Company overview Jan 9, 2014 527
Veloxis Pharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Diurnal-Independent Administration of Envarsus. Jan 8, 2014 647
Drug Designation, Conference Participations, Induction of Winners, Software Solution Deployment, and Patent Issuance - Research Report on GSK, Centene, WuXi PharmaTech, Allscripts, and Immunomedics. Report Jan 6, 2014 1554
Triune synergy in biomedical research: uniting pharmaceutical companies, university researchers, and the NIH through the drug repurposing project at NCATS. Yagi, Brian F. Jan 1, 2014 13699
Patent Claims, Agreements, Quarterly Reports, Favorable Clinical Trial Results, and Dividends - Research Report on Acorda, Centene, Neogen, ImmunoGen, and West. Dec 24, 2013 1568
Actavis Confirms Generic NuvaRing Patent Challenge. Dec 24, 2013 928
Can-Fite Granted U.S. Patent for Utilization of A3 Adenosine Receptor as Biomarker to Predict Patient Response to CF101 in Autoimmune Inflammatory Indications. Dec 19, 2013 1008
United Kingdom : Oxford BioMedica inks agreement with GlaxoSmithKline PLC giving option for NON-EXCLUSIVE LICENCE. Dec 19, 2013 113
Biousian Biosystems Receives US Patent for Best-in-Class Analgesic. Dec 16, 2013 752
Biousian Biosystems Receives US Patent for Best-in-Class Analgesic. Dec 16, 2013 758
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma. Dec 11, 2013 819
Chinese Patent Medicine Industry Report, 2012-2015. Industry overview Dec 9, 2013 784
Chinese Patent Medicine Industry Report, 2012-2015. Industry overview Dec 9, 2013 792
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin. Report Dec 6, 2013 1590
Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead. Clinical report Dec 5, 2013 1465
Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment. Dec 4, 2013 1514
Purdue Pharma L.P. Announces Resolution of OxyContin (oxycodone HCl controlled-release) Tablets CII Patent Lawsuit with Impax Laboratories, Inc. Dec 3, 2013 1105
Pharmaceutical pricing system in need of reform: Novartis Vice Chairman. Dec 3, 2013 1318
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. Dec 3, 2013 516
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. Dec 3, 2013 522
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand. Dec 2, 2013 838
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand. Dec 2, 2013 843
Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology. Nov 26, 2013 600
Drug Designation, Patents, Milestone Payment, Quarterly Result, and Medical Study - Research Report on The Medicines Company, VIVUS, Isis, HeartWare, and Masimo. Nov 20, 2013 1538
Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies. Report Nov 19, 2013 1635
Viteava Pharmaceuticals Executes Worldwide Exclusive License. Nov 19, 2013 727
Mylan Launches First Generic Focalin XR Capsules, 30 mg. Nov 18, 2013 400
Actavis Confirms Generic Axiron Patent Challenge. Nov 14, 2013 854
VIRUN[R] & Vital Pharmaceuticals[R] Expand Operations to Offer a Combined 29 Patents for Raw Material Manufacturing and Finished Product Capabilities. Nov 5, 2013 854
U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure. Nov 5, 2013 1369
Mylan Confirms First-to-File Patent Challenge Relating to Uloric. Nov 1, 2013 578
Actavis Confirms Generic Absorica Patent Challenge. Oct 31, 2013 885
D-Pharm Granted Patent in US and China for its Phase II Product THR-18. Oct 30, 2013 544
Sanofi Q3 2013 Marks the End of the Patent Cliff Period. Oct 30, 2013 1973
D-Pharm Granted Patent in US and China for its Phase II Product THR-18. Oct 30, 2013 549
Actavis Confirms Generic Acanya Gel Patent Challenge. Oct 28, 2013 1047
Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals. Conference news Oct 28, 2013 1639
South Africa: How a Patent Is Blocking Access to a Life-Saving TB Medicine. Oct 24, 2013 460
Mission Pharmacal Settles Patent Infringement Suit Against PureTek. Oct 16, 2013 635
Fuisz Pharma LLC Announces Allowance of Patent Claims by the Israeli Patent Office Relating to the Programming of Bodily Fluid Analyzers. Oct 15, 2013 481
AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM) and its Proprietary Platform Technologies. Oct 8, 2013 1216
Actavis Confirms Generic Suboxone Sublingual Film Patent Challenge. Oct 8, 2013 890
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform. Clinical report Oct 1, 2013 1305
Contending issues of intellectual property rights protection and indigenous knowledge of pharmacology in Africa South of the Sahara. Ezeanya, Chika A. Essay Oct 1, 2013 6644
Mylan Launches First Generic VFEND for Oral Suspension. Sep 30, 2013 454
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst. Report Sep 27, 2013 1606
Mylan Confirms First-to-File Patent Challenge Relating to SAVELLA. Sep 25, 2013 622
ITIP ProFiciency Announces Expanded Website and Marketing Initiatives to Meet Global Demand for IP Cost Management. Sep 23, 2013 571
An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India. Jain, Dipika; Darrow, Jonathan J. Sep 22, 2013 13952
Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property. Sep 18, 2013 439
Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property. Sep 18, 2013 444
NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi. Clinical report Sep 17, 2013 1657
Access Pharmaceuticals Awarded Second European Patent for MuGard. Sep 12, 2013 686
Access Pharmaceuticals Awarded Second European Patent for MuGard. Sep 12, 2013 693
European Patent Office Grants a Patent for the Treatment of Sjogren's Syndrome. Sep 3, 2013 462
Bayer's patent on birth control pill Yaz is invalid. Beck, Julie Sep 1, 2013 151
Actavis Confirms Generic Rayos Patent Challenge. Aug 27, 2013 753

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters